Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride Capsule
Product Images NDC 49884-151

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride (NDC 49884-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metronidazole-stru-formula (Bismuth Subcitrate Potassium Metronidazole And Tet 1)

Metronidazole-stru-formula (Bismuth Subcitrate Potassium Metronidazole And Tet 1)
This is a description of the molecular weight of a compound. The molecular weight is given as 171.2.*
FDA Label Image

Tetracycline-stru-formula (Bismuth Subcitrate Potassium Metronidazole And Tet 2)

Tetracycline-stru-formula (Bismuth Subcitrate Potassium Metronidazole And Tet 2)
This is a statement indicating the molecular weight of a substance, likely a chemical compound or molecule. The molecular weight is given as 480.90, although no information is provided about what substance this weight corresponds to.*
FDA Label Image

Bmt Capsules (Bismuth Subcitrate Potassium Metronidazole And Tet 3)

Bmt Capsules (Bismuth Subcitrate Potassium Metronidazole And Tet 3)
Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride Capsules are available from Par Pharmaceutical. Each capsule contains Bismuth Subcitrate, Potassium 140 mg, Metronidazole 125 mg, and Tetracycline HCI 125 mg. The recommended dose is to take three capsules four times a day. The package insert contains full instructions. The capsules come in blister packs of three and are available only by prescription.*
FDA Label Image

Bmt Capsules (Bismuth Subcitrate Potassium Metronidazole And Tet 4)

Bmt Capsules (Bismuth Subcitrate Potassium Metronidazole And Tet 4)
This is a description of Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride capsules, typically used for treating patients with Helicobacter pylori infection and duodenal ulcer disease. It contains dosage instructions and lists the ingredients contained in each capsule. The capsules are not to be stored above room temperature, and warnings and safety information can be found inside the box. The capsules are distributed by Par Pharmaceutical in Chestnut Ridge, NY and made in India by Par Formulations Private Limited.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.